Clinical Trial Update: Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating various anti-inflammatory agents for mild cognitive impairment or Alzheimer's disease was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Various anti-inflammatory agents

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-05-06